Skip to Main Content (Press Enter)

Logo UNIME
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze

Competenze e Professionalità
Logo UNIME

|

UNIFIND - Competenze e Professionalità

unime.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  1. Pubblicazioni

Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis

Articolo
Data di Pubblicazione:
2025
Abstract:
Among cardiomyopathies, the hypertrophic phenotype is the most common, and hypertrophic cardiomyopathy (HCM) phenocopies represent a heterogeneous group of conditions. They are defined by a left ventricular wall thickness ≥15 mm in the absence of other causes such as loading conditions, ischemia, or valvular disease. Although they mimic similar clinical and morphological features, their etiologies are distinct and include genetic, metabolic, and infiltrative mechanisms. Therefore, accurate classification and differential diagnosis are crucial for effective management and treatment. Sarcomeric HCM is the most frequent form, accounting for up to 60% of cases. However, numerous non-sarcomeric phenocopies exist, including amyloidosis, Fabry disease, glycogen storage disorders, RASopathies, and mitochondrial diseases. Clinical and imaging findings are essential to distinguish these entities from sarcomeric HCM. Electrocardiography, echocardiography, advanced modalities such as cardiac magnetic resonance (CMR), and specific laboratory tests all play a central role in guiding diagnosis. Genetic testing provides key insights into mutations and inheritance patterns, further supporting definitive diagnosis. Correct identification of an HCM phenocopy carries important therapeutic implications, as disease-specific treatments can significantly improve prognosis. For example, targeted therapies exist for amyloidosis, Fabry disease, and certain metabolic or mitochondrial disorders, underlining the clinical relevance of an accurate diagnosis. This review aims to provide an overview of HCM phenocopies and assist clinicians in diagnostic reasoning. The first part addresses classification according to pathophysiological mechanisms, clinical features, and genetic background. The second part focuses on the stepwise approach to differential diagnosis, integrating clinical assessment, laboratory evaluation, ECG, echocardiography, and CMR findings.
Tipologia CRIS:
14.a.1 Articolo su rivista
Keywords:
cardiomyopathy; hypertrophic cardiomyopathies; HCM; phenocopies; classification; diagnosis; differential diagnosis; sarcomeric cardiomyopathy; amyloidosis; Fabry disease
Elenco autori:
Teresi, Lucio; Trimarchi, Giancarlo; Licordari, Roberto; Restelli, Davide; Taverna, Giovanni; Liotta, Paolo; Micari, Antonino; Smecca, Ignazio; Dendramis, Gregory; Turturiello, Dario; Chiara Latini, Alessia; Falasconi, Giulio; De Gregorio, Cesare; Crea, Pasquale; Dattilo, Giuseppe; Berruezo, Antonio; Micari, Antonio; Di Bella, Gianluca
Autori di Ateneo:
DATTILO Giuseppe
DE GREGORIO Cesare
DI BELLA Gianluca
MICARI Antonio
Link alla scheda completa:
https://iris.unime.it/handle/11570/3355470
Pubblicato in:
BIOMEDICINES
Journal
  • Dati Generali

Dati Generali

URL

https://www.mdpi.com/2227-9059/13/12/3062
  • Informazioni
  • Assistenza
  • Accessibilità
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Designed by Cineca | 26.6.1.0